CEACAM5 and neoplasm: For example, Xu et al. covalently conjugated a novel NK cell-engager (NKCE) bsAb targeting the NK cell marker CD16 and the tumor biomarker carcinoembryonic antigen (CEA) to the surface of PEGylated hollow mesoporous ruthenium NPs.